Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study

British Medical Journal

Volumn 321, Issue 7258, 2000, Pages 405-412

  Stratton, Irene M ^a   Adler, Amanda I ^a   Neil, H Andrew W ^b   Matthews, David R ^a   Manley, Susan E ^a   Cull, Carole A ^a   Hadden, David ^c   Turner, Robert C ^a   Holman, Rury R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; CATARACT; CATARACT EXTRACTION; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; VASCULAR DISEASE;

EID: 0034641568     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.321.7258.405     Document Type: Article

References (47)

1. 1 UKPDS Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
2. 2 Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258-68.
3. 3 Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (part 1). Diabetes Care 1978;1:168-88.
4. 4 Adler AI, Boyko EJ, Ahroni AJ, Stensel V, Forsberg RC, Smith DG. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle prospective diabetic foot study. Diabetes Care 1997;20:1162-7.
5. 5 UKPDS Group. Risk factors for coronary artery disease in non-insulin dependent diabetes (UKPDS 23). BMJ 1998;316:823-8.
6. 6 Kuusisto J. Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994;43:960-7.
7. 7 Lehto S, Ronnemaa T, Pyörälä K, Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 1996;27:63-8.
8. 8 Standl E, Balletshofer B, Dahl B, Weichenhain B, Stiegler H, Hormann A, et al. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich general practitioner project. Diabetologia 1996;39:1540-5.
9. 9 Groeneveld Y, Petri H, Hermans J, Springer MP. Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review. Diabet Med 1999;116:2-13.
10. 10 Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K. Ten-year cardiovascular mortality in relation in risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993;36:1175-84.
11. 11 Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycaemia on all-cause and cardiovascular mortality. Diabetes Care 1998;21:1167-72.
12. 12 Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the diabetes intervention study, 11-year follow-up. Diabetologia 1996;39:1577-83.
13. 13 Knuiman MW, Welborn TA, Whittall DE. An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model. Am J Epidemiol 1992;135:638-48.
14. 14 Sasaki A, Uehara M, Horiuchi N, Hasegawa K. A long-term follow-up study of diabetic patients in Osaka, Japan: mortality and causes of death. Tohoku J Exp Med 1983;141(suppl):639-44.
15. 15 Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, Forhan A, et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. Diabetes Care 1998;21:360-7.
16. 16 Fuller JH, Shipley MJ, Rose G, Jarett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. BMJ 1983;287:867-70.
17. 17 Jarrett RJ, Keen H. Hyperglycaemia and diabetes mellitus. Lancet 1976;ii:1009-12.
18. 18 Pettitt DJ, Knowler WC, Lisse JR, Bennett PH. Development of retinopathy and proteinuria in relation to plasma glucose concentration in Pima Indians. Lancet 1980;ii:1050-2.
19. 19 Krolewski AS, Laffel LM, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995;332:1251-5.
20. 20 DCCT Research Group. The absence of a glycemic threshold for the development of long-term complications: the perspective of the diabetes control and complications trial. Diabetes 1996;45:1289-98.
21. 21 Orchard T, Forrest K, Ellis D, Becker D. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. Arch Intern Med 1997;157:1851-6.
22. 22 Balkau B, Bertrais S, Ducimitière P, Eschwège E. Is there a glycemic threshold for mortality risk? Diabetes Care 1999;22:696-9.
23. 23 Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-40.
24. 24 UKPDS Group. UK prospective diabetes study VIII: study design, progress and performance. Diabetologia 1991;34:877-90.
25. 25 Manley SE, Cull CA, Holman RR. Relation of fasting plasma glucose on patients with type 2 diabetes in UKPDS randomised to and treated with diet or oral agents. Diabetes 2000:49(suppl 1):A180.
26. 26 UKPDS Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.
27. 27 UKPDS Group. UK prospective diabetes study XI: biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects. Diabet Med 1994;11:534-44.
28. 28 Cull CA, Manley SE, Stratton IM, Neil HAW, Ross IS, Holman RR. et al. Approach to maintaining comparability of biochemical data during long-term clinical trials. Clin Chem 1997;43:1913-8.
29. 29 Breslow NE, Day NE. The design and analysis of cohort studies. Statistical methods in cancer research II. Oxford: Oxford University Press, 1987.
30. 30 Agresti A. Categorical data analysis. New York: Wiley, 1990.
31. 31 Easton DF, Peto J, Babiker AG. Floating absolute risk: an alternate to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 1991;10:1025-35.
32. 32 UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998:317:703-13.
33. 33 SAS. Version 6. Cary, North Carolina: SAS Institute, 1990.
34. 34 MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
35. 35 Adler AI, Stratton IM, Neil HAW, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000;321:412-9.
36. 36 Stamler J. Epidemiology, established major risk factors and the primary prevention of coronary heart disease. In: Parmley WW, Chatterjee K, eds. Cardiology. Philadelphia: JB Lippincott, 1987:1-41.
37. 37 UKPDS Group. UK prospective diabetes study 24: relative efficacy of sulfonylurea, insulin and metformin therapy in newly diagnosed non-insulin dependent diabetes with primary diet failure followed for six years. Ann Intern Med 1998;128:165-75.
38. 38 American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1998;21(suppl 1):5-19.
39. 39 Franklin GF, Shetterly SM, Cohen JA, Baxter J, Hamman RF. Risk factors for distal symmetric neuropathy in NIDDM.The San Luis Valley diabetes study. Diabetes Care 1994:1172-7.
40. 40 Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the US population. Diabetes Care 1993; 16:1446-52.
41. 41 Adler AI, Boyko FJ, Ahroni JH, Smith DG. Lower extremity amputation in diabetes mellitus: the independent effects of peripheral vascular disease, sensory neuropathy and foot ulcers. Diabetes Care 1999;22: 1029-35.
42. 42 Adler AI, Matthews D, Holman RR, Turner RC. Type 2 diabetes and death: causes, estimated life expectancy and mortality rates - the UK prospective diabetes study. Diabetes 1998;47(suppl 1):A71.
43. 43 Palumbo PJ, Elveback LR, Chu CP, Connolly DC, Kurland LT. Diabetes mellitus: incidence, prevalence, survivorship and causes of death in Rochester, Minnesota, 1945-1970. Diabetes 1976;25:566-73.
44. 44 Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetelogia 1987;30:123-31.
45. 45 Goodkin G. Mortality in diabetes. A 20 year mortality study. J Occup Med 1975;17:716-21.
46. 46 Wetterhall SF, Olson DR, DeStefano F, Stevenson JM, Ford ES, German RR, et al. Trends in diabetes and diabetic complications, 1980-1987. Diabetes Care 1992;15:960-7.
47. 47 Stamler J, Vaccaro O, Neaton JD, Wentwotth D. Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993;16:434-44.